Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 2.175
+0.025 (1.16%)
Sep 4, 2026, 5:03 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 12.32 million as of September 4, 2026. Its market cap has increased by 229.24% in one year.
Market Cap
12.32M
Enterprise Value
12.21M
Revenue
585.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.18
ChartMarket Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 12.32M, a decrease of -63.38%. That is a compound annual growth rate of -19.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 12.32M | 34.92% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SkinBioTherapeutics | 24.62M |
| ImmuPharma | 22.34M |
| IXICO | 16.35M |
| Fusion Antibodies | 15.33M |
| Palatin Technologies | 14.57M |
| Aptamer Group | 12.09M |
| Solvonis Therapeutics | 8.34M |
| Cizzle Biotechnology Holdings | 6.37M |